• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性高血压与耐药性高血压。

Refractory versus resistant hypertension.

作者信息

Siddiqui Mohammed, Calhoun David A

机构信息

Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

Curr Opin Nephrol Hypertens. 2017 Jan;26(1):14-19. doi: 10.1097/MNH.0000000000000286.

DOI:10.1097/MNH.0000000000000286
PMID:27798457
Abstract

PURPOSE OF REVIEW

Refractory hypertension is a recently proposed phenotype of antihypertensive treatment failure. As such it represents an extreme subtype of resistant or difficult-to-treat hypertension. Resistant hypertension is relatively common with an estimated prevalence of 10-20% of treated hypertensive patients. It is typically defined as having an uncontrolled blood pressure on three or more antihypertensive medications, including a diuretic. Refractory hypertension is rare with a prevalence of approximately 5% of patients with uncontrolled resistant hypertension. It is defined as an uncontrolled blood pressure with the use of five or more antihypertensive medications, including a long-acting thiazide diuretic, such as chlorthalidone, and a mineralocorticoid receptor antagonist such as spironolactone.

RECENT FINDINGS

Persistent excess fluid retention is thought to commonly underlie development of resistant hypertension, recent studies suggest that refractory may be more likely attributable to heightened sympathetic output as opposed to inappropriate fluid retention.

SUMMARY

Treatment recommendations for resistant hypertension are generally based on intensification of diuretic therapy, especially with combined use of chlorthalidone and spironolactone. Although fuller elucidation is needed, such an approach may not be appropriate for refractory hypertension, which instead, may require effective sympathetic inhibition, either with medications or device-based approaches.

摘要

综述目的

难治性高血压是最近提出的一种抗高血压治疗失败的表型。因此,它代表了难治性或难以治疗的高血压的一种极端亚型。难治性高血压相对常见,估计在接受治疗的高血压患者中患病率为10%-20%。它通常被定义为在使用三种或更多种抗高血压药物(包括利尿剂)的情况下血压仍未得到控制。难治性高血压较为罕见,在血压未得到控制的难治性高血压患者中患病率约为5%。它被定义为在使用五种或更多种抗高血压药物(包括长效噻嗪类利尿剂如氯噻酮和盐皮质激素受体拮抗剂如螺内酯)的情况下血压仍未得到控制。

最新发现

持续性液体潴留过多被认为是难治性高血压发生的常见原因,最近的研究表明,难治性高血压更可能归因于交感神经输出增加,而非不适当的液体潴留。

总结

难治性高血压的治疗建议通常基于强化利尿治疗,尤其是联合使用氯噻酮和螺内酯。尽管需要更全面的阐释,但这种方法可能不适用于难治性高血压,难治性高血压可能需要通过药物或基于器械的方法进行有效的交感神经抑制。

相似文献

1
Refractory versus resistant hypertension.顽固性高血压与耐药性高血压。
Curr Opin Nephrol Hypertens. 2017 Jan;26(1):14-19. doi: 10.1097/MNH.0000000000000286.
2
Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.难治性和顽固性高血压:抗高血压治疗抵抗与治疗失败
Can J Cardiol. 2016 May;32(5):603-6. doi: 10.1016/j.cjca.2015.06.033. Epub 2015 Jul 8.
3
Treatment of Resistant and Refractory Hypertension.难治性高血压的治疗。
Circ Res. 2019 Mar 29;124(7):1061-1070. doi: 10.1161/CIRCRESAHA.118.312156.
4
Refractory versus resistant hypertension: Novel distinctive phenotypes.顽固性高血压与难治性高血压:新的独特表型。
J Nat Sci. 2017 Sep;3(9).
5
Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.抗高血压药物的依从性与真性难治性高血压的确诊。
Hypertension. 2020 Feb;75(2):510-515. doi: 10.1161/HYPERTENSIONAHA.119.14137. Epub 2019 Dec 9.
6
Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes.难治性高血压并非归因于心血腔容量确定的血管内液潴留。
Hypertension. 2018 Aug;72(2):343-349. doi: 10.1161/HYPERTENSIONAHA.118.10965. Epub 2018 Jun 4.
7
[Therapy Resistant and Refractory Hypertension].[难治性和顽固性高血压]
Dtsch Med Wochenschr. 2020 Jan;145(2):87-91. doi: 10.1055/a-1031-0612. Epub 2020 Jan 20.
8
Controversies in Hypertension V: Resistant and Refractory Hypertension.高血压争议之五:顽固性高血压与难治性高血压
Am J Med. 2024 Jan;137(1):12-22. doi: 10.1016/j.amjmed.2023.09.015. Epub 2023 Oct 12.
9
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.顽固性高血压:交感神经活动增强作为抗高血压治疗失败原因的证据
Hypertension. 2015 Jul;66(1):126-33. doi: 10.1161/HYPERTENSIONAHA.115.05449. Epub 2015 May 18.
10
Resistant and refractory hypertension: two sides of the same disease?顽固性高血压与难治性高血压:同一种疾病的两面?
J Bras Nefrol. 2019 Apr-Jun;41(2):266-274. doi: 10.1590/2175-8239-jbn-2018-0108. Epub 2018 Dec 6.

引用本文的文献

1
A scoping review of neuromodulation techniques for controlling blood pressure: what are the ups and downs to this approach?一项关于控制血压的神经调节技术的范围综述:这种方法的优缺点是什么?
Bioelectron Med. 2025 Aug 15;11(1):19. doi: 10.1186/s42234-025-00181-w.
2
Screening of serum markers in patients with resistant hypertension.顽固性高血压患者血清标志物的筛查
Heliyon. 2024 Aug 14;10(17):e36333. doi: 10.1016/j.heliyon.2024.e36333. eCollection 2024 Sep 15.
3
Long-term blood pressure outcomes of laparoscopic adrenalectomy in trHTN patients.
经皮肾镜取石术治疗trHTN患者的长期血压结局
J Transl Int Med. 2021 Jan 5;11(3):275-281. doi: 10.2478/jtim-2023-0107. eCollection 2023 Sep.
4
O-Linked β--Acetylglucosamine Modification: Linking Hypertension and the Immune System.O-连接 β-N-乙酰氨基葡萄糖修饰:连接高血压与免疫系统。
Front Immunol. 2022 Mar 17;13:852115. doi: 10.3389/fimmu.2022.852115. eCollection 2022.
5
Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis.难治性高血压:一项侧重于预后的叙述性系统评价
Curr Hypertens Rep. 2022 Apr;24(4):95-106. doi: 10.1007/s11906-022-01165-w. Epub 2022 Feb 2.
6
Prevalence, risk factors and impact on outcomes of 30-day unexpected rehospitalization in incident peritoneal dialysis patients.新诊断腹膜透析患者 30 天内非预期再住院的发生率、风险因素及其对结局的影响。
BMC Nephrol. 2021 Jan 6;22(1):4. doi: 10.1186/s12882-020-02201-0.
7
Clinical Characteristics of Resistant vs. Refractory Hypertension in a Population of Hypertensive Afrodescendants.高血压非洲裔人群中耐药性与难治性高血压的临床特征。
Arq Bras Cardiol. 2020 Jul;115(1):31-39. doi: 10.36660/abc.20190218. Epub 2020 Aug 7.
8
Recent advances in understanding and managing resistant/refractory hypertension.难治性/顽固性高血压的认识与管理的最新进展
F1000Res. 2020 Mar 9;9. doi: 10.12688/f1000research.21669.1. eCollection 2020.
9
Resistant and refractory hypertension: two sides of the same disease?顽固性高血压与难治性高血压:同一种疾病的两面?
J Bras Nefrol. 2019 Apr-Jun;41(2):266-274. doi: 10.1590/2175-8239-jbn-2018-0108. Epub 2018 Dec 6.
10
Hypertension: a new treatment for an old disease? Targeting the immune system.高血压:一种针对免疫系统的古老疾病的新疗法?
Br J Pharmacol. 2019 Jun;176(12):2028-2048. doi: 10.1111/bph.14436. Epub 2018 Jul 31.